Press release
Global Peptide Therapeutics Market Key Players, Synthesis Technology, Manufacturing Type, Covid-19 Impact and Forecasts 2021-2025
The global peptide therapeutics market is expected to record a value of US$42.22 billion in 2025, witnessing growth at a CAGR of 6.95%, for the duration spanning 2021-2025. The factors such as surging prevalence of cancer, rising healthcare expenditure, growing incidence of metabolic disorders, increasing geriatric population and accelerating number of approved peptide-based therapeutic drugs. However, the market growth would be challenged by availability of generic or biosimilar peptide therapeutic drugs, high cost of developing drugs and stringent regulatory requirements and production complexity of peptides. The market is anticipated to experience certain trends like expanding volume of peptides driven by generics, rapid adoption of outsourced peptide API and rising investments in research and development of novel drugs.Get a Free Sample Copy of Global Peptide Therapeutics Market Research Report at https://www.reportsnreports.com/contacts/requestsample.aspx?name=4763638
The global peptide therapeutics market can be segmented on the basis of type, synthesis technology, manufacturing type and application. Based on type, the market can be bifurcated into innovative and generic. According to synthesis technology, the market can be categorized into Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS) and Hybrid Technology. Whereas, on the basis of manufacturing type, the market can be divided outsourced and in-house. In terms of application, the global peptide therapeutics market can be split into chemotherapy, gastroenterology, analgesia, diabetes, pediatric & neonatology and other applications.
The fastest growing regional market is North America due to increasing research and development activities for the development of innovative peptide therapeutics and improvements in healthcare infrastructure coupled with growing prescription of peptide therapeutics on account of high presence of a large number of patients with chronic diseases such as diabetes and cancer.
Scope of the report:
• The report provides a comprehensive analysis of the global peptide therapeutics market segmented on the basis of type, synthesis technology, manufacturing type and application region.
• The major regional and country markets (North America, Europe, Middle East & Africa, Asia Pacific and Latin America) have been analyzed.
• The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
• The competitive landscape of the market, along with the company profiles of leading players (Novartis International AG, GlaxoSmithKline PLC, Bristol Myers Squibb Co., Amgen Inc., Eli Lilly and Company and PolyPeptide Group AG) are also presented in detail.
Get 20% and More Discount on this Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=4763638
Key Target Audience:
• Peptide Manufacturers, Suppliers & Distributors
• Pharmaceutical, Biopharmaceutical & Biotechnological Companies
• Research and Development (R&D) Organizations
• Government Bodies & Regulating Authorities
Table of Contents:
1. Market Overview
1.1 Introduction
1.2 Manufacturing Process of Peptides
1.3 Classification of Peptides
1.4 Functional Classification of Therapeutic Peptides & Proteins
1.5 Examples of Peptide-based Drugs
1.6 Advantages and Disadvantages of Therapeutic Peptides
1.7 Source or Chemical Nature of Early Peptides
2. Impact of COVID-19
2.1 Adoption of Peptides in COVID-19 Related Research
2.2 Disruptions in Clinical Trials
3. Global Market Analysis
3.1 Global Peptide Therapeutics Market by Value
3.2 Global Peptide Therapeutics Market Forecast by Value
3.3 Global Peptide Therapeutics Market by Type
3.3.1 Global Innovative Peptide Therapeutics Market by Value
3.3.2 Global Innovative Peptide Therapeutics Market Forecast by Value
3.3.3 Global Generic Peptide Therapeutics Market by Value
3.3.4 Global Generic Peptide Therapeutics Market Forecast by Value
3.4 Global Peptide Therapeutics Market by Synthesis Technology
3.4.1 Global Solid Phase Peptide Synthesis Therapeutics Market by Value
3.4.2 Global Solid Phase Peptide Synthesis Therapeutics Market Forecast by Value
3.4.3 Global Liquid Phase Peptide Synthesis Therapeutics Market by Value
3.4.4 Global Liquid Phase Peptide Synthesis Therapeutics Market Forecast by Value
3.4.5 Global Hybrid Technology Synthesis Therapeutics Market by Value
3.4.6 Global Hybrid Technology Synthesis Therapeutics Market Forecast by Value
3.5 Global Peptide Therapeutics Market by Manufacturing Type
3.5.1 Global Outsourced Peptide Therapeutics Market Forecast by Value
3.5.2 Global In-house Peptide Therapeutics Market Forecast by Value
3.6 Global Peptide Therapeutics Market by Application
3.6.1 Global Metabolic Disorders Peptide Therapeutics Market by Value
3.6.2 Global Metabolic Disorders Peptide Therapeutics Market Forecast by Value
3.6.3 Global Oncology Peptide Therapeutics Market by Value
3.6.4 Global Oncology Peptide Therapeutics Market Forecast by Value
3.6.5 Global Gastrointestinal Disorders Peptide Therapeutics Market by Value
3.6.6 Global Gastrointestinal Disorders Peptide Therapeutics Market Forecast by Value
3.6.7 Global Cardiovascular Disorders Peptide Therapeutics Market by Value
3.6.8 Global Cardiovascular Disorders Peptide Therapeutics Market Forecast by Value
3.6.9 Global Neurological Disorders Peptide Therapeutics Market by Value
3.6.10 Global Neurological Disorders Peptide Therapeutics Market Forecast by Value
3.7 Global Peptide Therapeutics Market by Region
Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=4763638
4. Regional Market Analysis
4.1 North America
4.1.1 North America Peptide Therapeutics Market by Value
4.1.2 North America Peptide Therapeutics Market Forecast by Value
4.1.3 The U.S. Peptide Therapeutics Market Forecast by Value
4.1.4 The U.S. Peptide Therapeutics Market Forecast by Type
4.2 Europe, Middle East & Africa
4.2.1 Europe, Middle East & Africa Peptide Therapeutics Market by Value
4.2.2 Europe, Middle East & Africa Peptide Therapeutics Market Forecast by Value
4.3 Asia Pacific
4.3.1 Asia Pacific Peptide Therapeutics Market by Value
4.3.2 Asia Pacific Peptide Therapeutics Market Forecast by Value
4.4 Latin America
4.4.1 Latin America Peptide Therapeutics Market by Value
4.4.2 Latin America Peptide Therapeutics Market Forecast by Value
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Surging Prevalence of Cancer
5.1.2 Rising Healthcare Expenditure
5.1.3 Growing Incidence of Metabolic Disorders
5.1.4 Increasing Geriatric Population
5.1.5 Accelerating Number of Approved Peptide-based Therapeutic Drugs
5.2 Key Trends and Developments
5.2.1 Expanding Volume of Peptides driven by Generics
5.2.2 Rapid Adoption of Outsourced Peptide API
5.2.3 Rising Investments in Research and Development of Novel Drugs
5.3 Challenges
5.3.1 Availability of Generic or Biosimilar Peptide Therapeutic Drugs
5.3.2 High Cost of Developing Drugs and Stringent Regulatory Requirements
5.3.3 Production Complexity of Peptides
6. Competitive Landscape
6.1 Global Market
6.1.1 Revenue Comparison of Key Players
6.1.2 Market Capitalization Comparison of Key Players
6.1.3 R&D Comparison of Key Players
7. Company Profiles
7.1 Novartis International AG
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 GlaxoSmithKline PLC
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Bristol Myers Squibb Co.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 Amgen Inc.
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies
7.5 Eli Lilly and Company
7.5.1 Business Overview
7.5.2 Financial Overview
7.5.3 Business Strategies
7.6 PolyPeptide Group AG
7.6.1 Business Overview
7.6.2 Financial Overview
7.6.3 Business Strategies
List of Figures
Manufacturing Process of Peptides
Classification of Peptides
Functional Classification of Therapeutic Peptides & Proteins
Advantages and Disadvantages of Therapeutic Peptides
Global Most Affected Clinical Trials by Therapy Area (2020)
Global Peptide Therapeutics Market by Value (2016-2020)
Global Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Peptide Therapeutics Market by Type (2020)
Global Innovative Peptide Therapeutics Market by Value (2016-2020)
Global Innovative Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Generic Peptide Therapeutics Market by Value (2016-2020)
Global Generic Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Peptide Therapeutics Market by Synthesis Technology (2020)
Global Solid Phase Peptide Synthesis Therapeutics Market by Value (2016-2020)
Global Solid Phase Peptide Synthesis Therapeutics Market Forecast by Value (2021-2025)
Global Liquid Phase Peptide Synthesis Therapeutics Market by Value (2016-2020)
Global Liquid Phase Peptide Synthesis Therapeutics Market Forecast by Value (2021-2025)
Global Hybrid Technology Synthesis Therapeutics Market by Value (2016-2020)
Global Hybrid Technology Synthesis Therapeutics Market Forecast by Value (2021-2025)
Global Peptide Therapeutics Market by Manufacturing Type (2020)
Global Outsourced Peptide Therapeutics Market Forecast by Value (2020-2025)
Global In-house Peptide Therapeutics Market Forecast by Value (2020-2025)
Global Peptide Therapeutics Market by Application (2020)
Global Metabolic Disorders Peptide Therapeutics Market by Value (2016-2020)
Global Metabolic Disorders Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Oncology Peptide Therapeutics Market by Value (2016-2020)
Global Oncology Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Gastrointestinal Disorders Peptide Therapeutics Market by Value (2016-2020)
Global Gastrointestinal Disorders Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Cardiovascular Disorders Peptide Therapeutics Market by Value (2016-2020)
Global Cardiovascular Disorders Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Neurological Disorders Peptide Therapeutics Market by Value (2016-2020)
Global Neurological Disorders Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Peptide Therapeutics Market by Region (2020)
North America Peptide Therapeutics Market by Value (2016-2020)
North America Peptide Therapeutics Market Forecast by Value (2021-2025)
The U.S. Peptide Therapeutics Market Forecast by Value (2020-2025)
The U.S. Peptide Therapeutics Market by Type (2020-2025)
Europe, Middle East & Africa Peptide Therapeutics Market by Value (2016-2020)
Europe, Middle East & Africa Peptide Therapeutics Market Forecast by Value (2021-2025)
Asia Pacific Peptide Therapeutics Market by Value (2016-2020)
Asia Pacific Peptide Therapeutics Market Forecast by Value (2021-2025)
Latin America Peptide Therapeutics Market by Value (2016-2020)
Latin America Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Cancer Prevalence (2018-2023)
Global Healthcare Expenditure Per Capita (2016-2020)
Global Diabetes Prevalence (2010-2045)
Global Population Ages 65 Years and Above (2016-2020)
Number of Approved/Launched Peptide Therapeutic Drugs Worldwide (2020-2025)
Global GLP-1 Market Development (2018-2027)
Global In-House vs. Outsourced Peptide API Market Development (2020-2025)
Global Spending on Pharmaceutical Research and Development (2018-2026)
Global Biosimilar Therapeutic Peptides Market (2020-2025)
Novartis International AG Net Sales and Net Income (2016-2020)
Novartis International AG Net Sales by Segment (2020)
Novartis International AG Net Sales by Region (2020)
GlaxoSmithKline PLC Turnover and Profit (2016-2020)
GlaxoSmithKline PLC Turnover by Segment (2020)
GlaxoSmithKline PLC Turnover by Region (2020)
Bristol Myers Squibb Co. Total Revenue and Net Earnings (2016-2020)
Bristol Myers Squibb Co. Total Revenue by Region (2020)
Amgen Inc. Revenue and Net Income (2016-2020)
Amgen Inc. Revenue by Region (2020)
Eli Lilly and Company Revenue and Net Income (2016-2020)
Eli Lilly and Company Revenue by Region (2020)
PolyPeptide Group AG Revenue and Net Income (2018-2020)
PolyPeptide Group AG Revenue by Segment (2020)
PolyPeptide Group AG Revenue by Region (2020)
List of Tables
Difference between Peptides, Small Molecules & Biologics
Examples of Peptide-based Drugs Available in the Market
Source or Chemical Nature of Early Peptides
Synthetic Peptides in Development of COVID-19 (2020)
Revenue Comparison of Key Players (2020)
Market Capitalization Comparison of Key Players (2021)
R&D Comparison of Key Players (2020)
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
+ 1 888 391 5441
sales@reportsandreports.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Peptide Therapeutics Market Key Players, Synthesis Technology, Manufacturing Type, Covid-19 Impact and Forecasts 2021-2025 here
News-ID: 2356104 • Views: …
More Releases from ReportsnReports
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices
Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact!
Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices.
Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register
MarketsandMarkets presents…
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH.
This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the…
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays.
Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/
This conference aims to bring together all the stakeholders to discuss the obstacles in achieving…
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying…
More Releases for Peptide
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market …
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).
[https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
